Carmel, IN, United States of America

Stephen M Spaethe


Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Stephen M. Spaethe: Innovator in Oncology**

Introduction

Stephen M. Spaethe is a prominent inventor based in Carmel, Indiana, recognized for his significant contributions to the field of oncology. With a total of four patents to his name, he has established himself as a creative force in the medical research community, particularly in developing solutions for treating resistant tumors.

Latest Patents

Among his notable inventions, Stephen's latest patents include a method for treating resistant tumors, which provides a groundbreaking approach to reversing multidrug resistance. This invention details administering a multidrug resistance reversing amount of a series of phenoxy compounds that effectively target multidrug-resistant tumors. Another important patent involves benzothiophenes substituted at the 3-carbonyl, wherein he has outlined compounds that demonstrate potential therapeutic benefits.

Career Highlights

Stephen M. Spaethe currently works for Eli Lilly and Company, a leading global pharmaceutical company. His role there has allowed him to apply his inventive ideas in practical scenarios, translating laboratory research into potential treatments for patients. His ongoing dedication to innovation has contributed to Eli Lilly's overall mission to create advancements in healthcare.

Collaborations

Throughout his career, Stephen has collaborated with esteemed colleagues such as Donald G. Carlson and George J. Cullinan. These partnerships have fostered a rich environment for creativity and collective problem-solving, enhancing the caliber of research being pursued at Eli Lilly.

Conclusion

In summary, Stephen M. Spaethe's inventions and patents illustrate his commitment to addressing complex medical challenges. His work at Eli Lilly and valuable collaborations continue to pave the way for innovative approaches to treat resistant tumors and improve patient outcomes. Stephen's journey as an inventor underscores the importance of research and innovation in the ever-evolving landscape of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…